0001328143-21-000063.txt : 20210608
0001328143-21-000063.hdr.sgml : 20210608
20210608173233
ACCESSION NUMBER: 0001328143-21-000063
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210607
FILED AS OF DATE: 20210608
DATE AS OF CHANGE: 20210608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DEMSKI MARTHA J
CENTRAL INDEX KEY: 0001198230
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36399
FILM NUMBER: 211003165
MAIL ADDRESS:
STREET 1: 7770 REGENTS ROAD SUITE 113-505
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adamas Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001328143
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 421560076
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1900 POWELL ST., SUITE 1000
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 510-450-3554
MAIL ADDRESS:
STREET 1: 1900 POWELL ST., SUITE 1000
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: NeuroMolecular Pharmaceuticals Inc
DATE OF NAME CHANGE: 20050524
4
1
wf-form4_162318792641400.xml
FORM 4
X0306
4
2021-06-07
0
0001328143
Adamas Pharmaceuticals Inc
ADMS
0001198230
DEMSKI MARTHA J
C/O ADAMAS PHARMACEUTICALS, INC.
1900 POWELL ST., SUITE 1000
EMERYVILLE
CA
94608
1
0
0
0
Common Stock
2021-06-07
4
S
0
2000
5.17
D
8000
D
Common Stock
13000
I
Martha J. Demski U/D/T 10/1/1994, Martha J. Demski Trustee
This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax obligations in connection with the vesting of the reporting person's director restricted stock awards.
/s/ Christopher B. Prentiss, Attorney-in-fact
2021-06-08